BIAF
BioAffinity Technologies Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.12
+1.05 ▲ +98.13%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$1.95
-0.17 ▼ -7.96%
| Index | - | P/E | - | EPS (ttm) | -20.87 | Insider Own | 3.38% | Shs Outstand | 0.00B | Perf Week | 103.85% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | 113.49% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 5.31% | Short Float | 5.09% | Perf Quarter | 25.44% |
| Income | -0.01B | P/S | 1.55 | EPS this Y | - | Inst Trans | -8.89% | Short Ratio | 0.43 | Perf Half Y | -72.28% |
| Sales | 0.01B | P/B | 1.31 | EPS next 5Y | - | ROA | -170.65% | Short Interest | 0.22M | Perf YTD | 79.66% |
| Book/sh | 1.62 | P/C | 1.48 | EPS past 3/5Y | 45.79% 21.77% | ROE | -301.83% | 52W High | -95.44% ($46.53) | Perf Year | -80.06% |
| Cash/sh | 1.43 | P/FCF | - | Sales past 3/5Y | 986.6% - | ROIC | -185.11% | 52W Low | 205.92% ($0.69) | Perf 3Y | -95.84% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 13.18% | Gross Margin | 23.21% | Volatility(W/M) | 22.66% 15.02% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 0.69 | Sales Y/Y TTM | -34.18% | Oper. Margin | -171.58% | ATR (14) | 0.24 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.58 | EPS Q/Q | - | Profit Margin | -241.96% | RSI (14) | 77.28 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.6 | Sales Q/Q | -27.85% | SMA20 | 89.02% ($1.12) | Beta | 2.28 | Target Price | $180 |
| Payout | - | Debt/Eq | 0.16 | Earnings | 3000000 | SMA50 | 82.22% ($1.16) | Rel Volume | 470.72 | Prev Close | $1.07 |
| Employees | 57 | LT Debt/Eq | 0.11 | EPS/Sales Surpr. | - | SMA200 | -52.4% ($4.45) | Avg Volume(3M) | 0.51M | Price | $2.12 |
| IPO | 2022/9/1 | Option/Short | No/No | Trades | 496248 | Volume | 240,989,590 | Change | 98.13% |
뉴스 로딩 중...